ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,786,457 | +111543.0% | 1,547,181 | 0.0% | 0.32% | -5.0% |
| Q1 2023 | $5,183 | -30.4% | 1,547,181 | 0.0% | 0.34% | -31.5% |
| Q4 2022 | $7,442 | -99.9% | 1,547,181 | 0.0% | 0.50% | -19.0% |
| Q3 2022 | $8,803,000 | -19.9% | 1,547,181 | 0.0% | 0.62% | -26.0% |
| Q2 2022 | $10,985,000 | -1.7% | 1,547,181 | 0.0% | 0.83% | -3.1% |
| Q1 2022 | $11,171,000 | -25.6% | 1,547,181 | -7.9% | 0.86% | -3.9% |
| Q4 2021 | $15,014,000 | -91.3% | 1,679,442 | -65.9% | 0.89% | -87.3% |
| Q3 2021 | $172,802,000 | +25.5% | 4,928,756 | -23.1% | 7.02% | +50.1% |
| Q2 2021 | $137,716,000 | -65.2% | 6,411,355 | 0.0% | 4.68% | -47.0% |
| Q1 2021 | $395,901,000 | +52.4% | 6,411,355 | 0.0% | 8.82% | +42.6% |
| Q4 2020 | $259,830,000 | – | 6,411,355 | – | 6.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |